Read More Pharma Industry News Bayer secures FDA approval for hemophilia A treatment drug Jivi In a major advancement for hemophilia A therapy, Bayer’s recombinant factor VIII (rFVIII) replacement therapy, Jivi (BAY94-9027), has… bypharmanewsdailySeptember 1, 2018
